Advanced search×

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Proc Natl Acad Sci U S A 69(1):196-9 (1972) PMID 4550505 PMCID 427574

Amphotericin B potentiates the antifungal effects of 5-fluorocytosine and rifampicin, probably by increasing the penetration of these agents through the fungal cytoplasmic membrane.

Version: za2963e q8za5 q8zbb q8zcf q8zd5 q8zef q8zf6 q8zg6

Similar articles you may find interesting…

  1. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers.

    Clin Exp Immunol 91(2):314-9 (1993) PMID 8428396 PMCID 1554683

    We determined the effects on endothelial monolayer permeability of acute agonists (thrombin and histamine), cytokines (tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), IL-1 and IL-4) and combinations of acute agonists and cytokines. Addition of thrombin in concentrations rangi...
  2. Host response to bovine respiratory pathogens.

    Anim Health Res Rev 10(2):141-3 (2009) PMID 20003650

    Bovine respiratory disease (BRD) involves complex interactions amongst viral and bacterial pathogens that can lead to intense pulmonary inflammation (fibrinous pleuropneumonia). Viral infection greatly increases the susceptibility of cattle to secondary infection of the lung with bacterial pathogens...
  3. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability

    Cytokine 40(2):7 (2007) PMID 17959386

    VEGF alone is twice as potent in interrupting tight junctions in an endothelial cell monolayer as Ang-2. However, both growth factors acting together increase permeability three times as much as VEGF alone. Treatments designed to reduce vascular permeability in diabetic macular oedema should conside...